{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:33:58Z","timestamp":1791286438741,"version":"4.1.0"},"publisher-location":"Boston, MA","reference-count":49,"publisher":"Springer US","isbn-type":[{"value":"9781461371809","type":"print"},{"value":"9781461548119","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999]]},"DOI":"10.1007\/978-1-4615-4811-9_40","type":"book-chapter","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T14:51:56Z","timestamp":1316098316000},"page":"383-389","source":"Crossref","is-referenced-by-count":9,"title":["Genetic Abnormalities and Drug Resistance in Acute Lymphoblastic Leukemia"],"prefix":"10.1007","author":[{"given":"Ching-Hon","family":"Pui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"40_CR1","doi-asserted-by":"crossref","unstructured":"Pui, C.-H., Mahmoud, H.H., Rivera, G.K., Hancock, M.L., Sandlund, J.T., Behm, F.G., et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood, 92 411\u2013415.","DOI":"10.1182\/blood.V92.2.411.414k34_411_415"},{"key":"40_CR2","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0031-3955(05)70532-0","volume":"44","author":"C-H Pui","year":"1997","unstructured":"Pui, C.-H. (1997) Acute lymphoblastic leukemia. Pediatr Clin North Am, 44, 831\u2013846.","journal-title":"Pediatr Clin North Am"},{"key":"40_CR3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1182\/blood.V85.3.751.bloodjournal853751","volume":"85","author":"GJL Kaspers","year":"1995","unstructured":"Kaspers, G.J.L., Smets, L.A., Pieters, R., Van Zantwijk, C.H., Van Wering, E.R., and Veerman, A.J.P. (1995) Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: Results of an in vitro study. Blood, 85, 751\u2013756.","journal-title":"Blood"},{"key":"40_CR4","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1172\/JCI117552","volume":"94","author":"TW Synold","year":"1994","unstructured":"Synold, T.W., Relling, M.V., Boyett, J.M., Rivera, G.K., Sandlund, J.T., Mahmoud, H., et al. (1994) Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J Clin Invest, 94, 1996\u20132001.","journal-title":"J Clin Invest"},{"key":"40_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1172\/JCI118474","volume":"97","author":"M Kumagai","year":"1996","unstructured":"Kumagai, M., Manabe, A., Pui, C.-H., Behm, F.G., Raimondi, S.C., Hancock, M.L., et al. (1996) Stroma-supported culture of childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J Clin Invest, 97, 755\u2013760.","journal-title":"J Clin Invest"},{"key":"40_CR6","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood.V79.12.3316.bloodjournal79123316","volume":"79","author":"MB Harris","year":"1992","unstructured":"Harris, M.B., Shuster, J.J., Carroll, A., Look, A.T., Borowitz, M.J., Crist, W.M., et al. (1992), Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A pediatric oncology group study. Blood, 79, 3316\u20133324.","journal-title":"Blood"},{"key":"40_CR7","first-page":"213","volume":"10","author":"SC Raimondi","year":"1996","unstructured":"Raimondi. S.C., Pui, C.-H., Hancock, M.L., Behm, F.G., Filatov, L., and Rivera, G.K. (1996) Heterogeneity of hyperdiploid (51\u201367) childhood acute lymphoblastic leukemia. Leukemia, 10, 213\u2013224.","journal-title":"Leukemia"},{"key":"40_CR8","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1182\/blood.V90.11.4559","volume":"90","author":"SC Raimondi","year":"1997","unstructured":"Raimondi, S.C., Shurtleff, S.A., Downing, J.R., Rubnitz, J., Mathew, S., Hancock, M., et al. (1997) 12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemia. Blood, 90, 4559\u20134566.","journal-title":"Blood"},{"key":"40_CR9","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1182\/blood.V88.11.4252.bloodjournal88114252","volume":"11","author":"TW McLean","year":"1996","unstructured":"McLean, T.W., Ringold, S., Neuberg, D., Stegmaier, K., Tantravahi, R., Ritz, J., et al. (1996) TEL\/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood, 11, 4252\u20134258.","journal-title":"Blood"},{"key":"40_CR10","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/sj.leu.2400779","volume":"11","author":"JE Rubnitz","year":"1997","unstructured":"Rubnitz, J.E., Behm, F.G., Pui, C.-H., Evans, W.E., Relling, M.V., Raimondi, S.C., et al. (1997) Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St. Jude Total Therapy Study XII. Leukemia, 11, 1201\u20131206.","journal-title":"Leukemia"},{"key":"40_CR11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V90.2.571","volume":"90","author":"A Borkhardt","year":"1997","unstructured":"Borkhardt, A., Cazzaniga, G., Viehmann, S., Valsecchi, M.G., Ludwig, W. D., Burci, L., et al. (1997) Incidence and clinical relevance of TEL\/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood, 90, 571\u2013577.","journal-title":"Blood"},{"key":"40_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.1365-2141.1997.3603174.x","volume":"99","author":"A Baruchel","year":"1997","unstructured":"Baruchel, A., Cayuela, J.M., Ballerini, P., Landman-Parker, J., Cezard, V, Firat, H., et al. (1997) The majority of myeloid-antigen positive (My+) childhood B-cell precursor acute lymphoblastic leukemias express TEL-AML1 fusion transcripts. Br J Hematol, 99, 101\u2013106.","journal-title":"Br J Hematol"},{"key":"40_CR13","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1200\/JCO.1997.15.3.1150","volume":"15","author":"JE Rubnitz","year":"1997","unstructured":"Rubnitz, J.E., Downing, J.R., Pui, C-H., Shurtleff, S.A., Raimondi, S.C., Evans, W.E., et al. (1997) TEL gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance. J Clin Oncol, 15, 1150\u20131157.","journal-title":"J Clin Oncol"},{"key":"40_CR14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1182\/blood.V89.4.1143","volume":"89","author":"JE Rubnitz","year":"1997","unstructured":"Rubnitz, J.E., Shuster, J., Land, V.J., Link, M.P., Pullen, J., Camitta, B.M., et al. (1997) Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: A pediatric oncology group study. Blood, 89, 1143\u20131146.","journal-title":"Blood"},{"key":"40_CR15","first-page":"329","volume":"39","author":"WM Whitehead","year":"1998","unstructured":"Whitehead, W.M., Payment, C., Vuchich, M-J., Cooley, L., Lauer, S.J., Mahoney, D.H., et al. (1998) The TEL-AML1 translocation and methotrexate polyglutamate (MTXPG) levels in childhood B-progenitor cell acute lymphoblastic leukemia (pro-B ALL): a pediatric oncology group study. Proc AACR, 39, 329.","journal-title":"Proc AACR"},{"key":"40_CR16","first-page":"1463","volume":"10","author":"M Nakao","year":"1996","unstructured":"Nakao, M., Yokota, S., Horiike, S., Taniwaki, M., Kashima, K., Sonoda, Y, et al. (1996) Detection and quantification of TEL\/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia, 10, 1463\u20131470.","journal-title":"Leukemia"},{"key":"40_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1046\/j.1365-2141.1997.312676.x","volume":"97","author":"C Lanza","year":"1997","unstructured":"Lanza, C., Volpe, G., Basso, G., Gottardi, E., Barisone, E., Spinelli, M., et al. (1997) Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. Br J Haematol, 97, 460\u2013462.","journal-title":"Br J Haematol"},{"key":"40_CR18","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1182\/blood.V90.12.4933","volume":"12","author":"J Harbott","year":"1997","unstructured":"Harbott, J., Viehmann, S., Borkhardt, A., Henze, G., and Lampert, F. (1997) Incidence of TEL\/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood, 12, 4933\u20134937.","journal-title":"Blood"},{"key":"40_CR19","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1182\/blood.V91.5.1716.1716_1716_1722","volume":"91","author":"K Seeger","year":"1998","unstructured":"Seeger, K., Adams, H-P., Buchwald, D., Beyermann, B., Kremens, B., Niemeyer, C., et al. (1998) TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. Blood, 91, 1716\u20131722.","journal-title":"Blood"},{"key":"40_CR20","first-page":"2730","volume":"92","author":"M Schrappe","year":"1998","unstructured":"Schrappe, M., Aric\u00f2, M., Harbott, J., Biondi, A., Zimmermann, M., Conter, V., et al. (1998) Ph+ childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood, 92, 2730\u20132741.","journal-title":"Blood"},{"key":"40_CR21","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/sj.leu.2400749","volume":"11","author":"RC Ribeiro","year":"1997","unstructured":"Ribeiro, R. C., Broniscer, A., Rivera, G.K., Hancock, M.L., Raimondi, S.C., Sandlund, J.T., et al. (1997) Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts. Leukemia, 11, 1493\u20131496.","journal-title":"Leukemia"},{"key":"40_CR22","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1182\/blood.V87.7.2870.bloodjournal8772870","volume":"87","author":"FG Behm","year":"1996","unstructured":"Behm, F.G., Raimondi, S.C., Frestedt, J.L., Liu, Q., Crist, W.M., Downing, J.R., et al. (1996) Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood, 87, 2870\u20132877.","journal-title":"Blood"},{"key":"40_CR23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood.V77.3.440.440","volume":"77","author":"C-H Pui","year":"1991","unstructured":"Pui, C.-H., Frankel, L.S., Carroll, A.J., Raimondi, S.C., Shuster, J.J., Head, D.R., et al. (1991) Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11) (q21;q23): A collaborative study of 40 cases. Blood, 77, 440\u2013447.","journal-title":"Blood"},{"key":"40_CR24","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood.V81.9.2386.2386","volume":"81","author":"C-S Chen","year":"1993","unstructured":"Chen, C-S., Sorensen, P.H.B., Domer, P.H., Reaman, G.H., Korsmeyer, S.J., Heerema, N.A., et al. (1993) Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood, 81, 2386\u20132393.","journal-title":"Blood"},{"key":"40_CR25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1200\/JCO.1994.12.5.909","volume":"12","author":"C-H Pui","year":"1994","unstructured":"Pui, C.-H., Behm, F.G., Downing, J.R., Hancock, M.L., Shurtleff, S.A., Ribeiro, R.C., et al. (1994) 11q23\/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol, 12, 909\u2013915.","journal-title":"J Clin Oncol"},{"key":"40_CR26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1182\/blood.V84.2.570.570","volume":"84","author":"JE Rubnitz","year":"1994","unstructured":"Rubnitz, J.E., Link, M.P., Shuster, J.J., Carroll, A.J., Hakami, N., Frankel, L.S., et al. (1994) Frequency and prognostic significance of HRX rearranagements in infant acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood, 84, 570\u2013573.","journal-title":"Blood"},{"key":"40_CR27","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/sj.leu.2401129","volume":"12","author":"R Pieters","year":"1998","unstructured":"Pieters, R., den Boer, M.L., Durian, M., Janka, G. Schmiegelow, K., Kaspers, G.J.L., et al. (1998) In vitro drug resistance testing in infant acute lymphoblastic leukemia cells \u2014 implications for treatment. Leukemia, 12, 1344\u20131348.","journal-title":"Leukemia"},{"issue":"Suppl 1","key":"40_CR28","first-page":"668a","volume":"88","author":"LB Silverman","year":"1996","unstructured":"Silverman, L. B., McLean, T.W., Donnelly, M.J., Gilliland, D.G., Gelber, R.D., and Sallan, S.E. (1996) Improved outcome for infants with acute lymphoblastic leukemia (ALL) with intensification of therapy. Blood, 88(Suppl 1), 668a.","journal-title":"Blood"},{"key":"40_CR29","first-page":"363","volume":"6","author":"LM Secker-Walker","year":"1992","unstructured":"Secker-Walker, L.M., Berger, R., Fenaux, P., Lai, J.L., Nelken, B., Garson, M., et al. (1992) Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia, 6, 363\u2013369.","journal-title":"Leukemia"},{"key":"40_CR30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1998.16.2.527","volume":"16","author":"FM Uckun","year":"1998","unstructured":"Uckun, F.M., Sensel, M.G., Sather, H.N., Gaynon, P.S., Arthur, D.C., Lange, B.J., et al. (1998) Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children\u2019s Cancer Group. J Clin Onc, 16, 527\u2013535.","journal-title":"J Clin Onc"},{"key":"40_CR31","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1200\/JCO.1994.12.12.2601","volume":"12","author":"C-H Pui","year":"1994","unstructured":"Pui, C.-H., Raimondi, S.C., Hancock, M.L., Rivera, G.K., Ribeiro, R.C., Mahmoud, H.H., et al. (1994) Immunologie, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative. J Clin Oncol, 12, 2601\u20132606.","journal-title":"J Clin Oncol"},{"key":"40_CR32","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood.V83.10.2922.2922","volume":"83","author":"MH Hsiao","year":"1994","unstructured":"Hsiao, M.H., Yu, A.L., Yeargin, J., Ku, D., and Haas, M. (1994) Monhereditary p53 mutations in T-Cell acute lymphoblastic leukemia are associated with the relapse phase. Blood, 83, 2922\u20132930.","journal-title":"Blood"},{"key":"40_CR33","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1182\/blood.V84.9.3105.3105","volume":"84","author":"MB Diccianni","year":"1994","unstructured":"Diccianni, M.B., Yu, J., Hsiao, M., Mukherjee, S., Shao, L.-E., and Yu, A.L. (1994) Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia. Blood, 84, 3105\u20133112.","journal-title":"Blood"},{"key":"40_CR34","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1182\/blood.V87.3.1155.bloodjournal8731155","volume":"87","author":"DI Marks","year":"1996","unstructured":"Marks, D.I., Kurz, B. W., Link, M.P., Ng, E., Shuster, J.J., Lauer, S.J., et al. (1996) High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis. Blood, 87, 1155\u20131161.","journal-title":"Blood"},{"key":"40_CR35","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1200\/JCO.1997.15.3.1158","volume":"15","author":"DI Marks","year":"1997","unstructured":"Marks, D.I., Kurz, B.W., Link, M.P., Ng, E., Shuster, J.J., Lauer, S.J., et al. (1997) Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia. J Clin Oncol, 15, 1158\u20131162.","journal-title":"J Clin Oncol"},{"key":"40_CR36","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood.V85.9.2321.bloodjournal8592321","volume":"85","author":"T Okuda","year":"1995","unstructured":"Okuda, T., Shurtleff, S.A., Valentine, M.B., Raimondi, S.C., Head, D.R., Behm, F., et al. (1995) Frequent deletion of p16 INK4a\/MTS1 and p15 INK4b\/MTS2 in pediatric acute lymphoblastic leukemia. Blood, 85, 2321\u20132330.","journal-title":"Blood"},{"key":"40_CR37","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.V86.2.755.bloodjournal862755","volume":"86","author":"S Takeuchi","year":"1995","unstructured":"Takeuchi, S., Bartram, C.R., Seriu, T., Miller, C.W., Tobler, A., Janssen, J.W.G., et al. (1995) Analysis of a family of cyclin-dependent kinase inhibitors: p15\/MTS2\/INK4B, p16\/MTS1\/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood, 86, 755\u2013760.","journal-title":"Blood"},{"key":"40_CR38","first-page":"255","volume":"10","author":"A Lolascon","year":"1996","unstructured":"Lolascon, A., Faienza, M.F., Coppola, B., della Ragione, F., Schettini, F., and Biondi, A. (1996) Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16INK4A and p18, in childhood T cell lineage acute lymphoblastic leukemias. Leukemia, 10, 255\u2013260.","journal-title":"Leukemia"},{"key":"40_CR39","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1200\/JCO.1996.14.5.1512","volume":"14","author":"M Heyman","year":"1996","unstructured":"Heyman, M., Rasool, O., Brandter, L.B., Liu, Y., Grand\u00e9r, D., S\u00f6derh\u00e4ll, S., et al. (1996) Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia. J Clin Oncol, 14, 1512\u20131520.","journal-title":"J Clin Oncol"},{"key":"40_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/08880019709030900","volume":"14","author":"M Zhou","year":"1997","unstructured":"Zhou, M., Gu, L., Yeager, A.M., and Findley, H.W. (1997) Incidence and clinical significance of CDKN2\/MTSl\/P16 ink4A and MTS2\/P15 ink4B gene deletions in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol, 14, 141\u2013150.","journal-title":"Pediatr Hematol Oncol"},{"key":"40_CR41","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1182\/blood.V89.11.4161","volume":"89","author":"UR Kees","year":"1997","unstructured":"Kees, U.R., Burton, P.R., L\u00fc, C., and Baker, D.L. (1997) Homozygous deletion of the p16\/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome. Blood, 89, 4161\u20134166.","journal-title":"Blood"},{"key":"40_CR42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","volume":"91","author":"T Kamijo","year":"1997","unstructured":"Kamijo, T., Zindy, F., Rousel, M.F., Quelle, D.E., Downing, J.R., Ashmun, R.A., et al. (1997) Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell, 91, 649\u2013659.","journal-title":"Cell"},{"key":"40_CR43","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1182\/blood.V91.3.1016","volume":"91","author":"B Gardie","year":"1998","unstructured":"Gardie, B., Cayuela, J-M., Martini, S., and Sigaux, F. (1998) Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia. Blood, 91, 1016\u20131020.","journal-title":"Blood"},{"key":"40_CR44","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm0697-614","volume":"3","author":"G Kroemer","year":"1997","unstructured":"Kroemer, G. (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med, 3, 614\u2013620.","journal-title":"Nature Med"},{"key":"40_CR45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/42867","volume":"387","author":"JC Reed","year":"1997","unstructured":"Reed, J.C. (1997) Double identity for proteins of the Bcl-2 family. Nature, 387, 773\u2013776.","journal-title":"Nature"},{"key":"40_CR46","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V87.3.1140.bloodjournal8731140","volume":"87","author":"E Coustan-Smith","year":"1996","unstructured":"Coustan-Smith, E., Kitanaka, A., Pui, C-H., McNinch, L., Evans, W.E., Raimondi, S.C., et al. (1996) Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia. Blood, 87, 1140\u20131146.","journal-title":"Blood"},{"key":"40_CR47","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1182\/blood.V89.10.3769","volume":"89","author":"FM Uckun","year":"1997","unstructured":"Uckun, F.M., Yang, Z., Sather, H., Steinherz, P., Nachman, J., Bostrom, B., et al. (1997) Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: A Children\u2019s Cancer Group study. Blood, 89, 3769\u20133777.","journal-title":"Blood"},{"key":"40_CR48","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/blood.V89.8.2986","volume":"89","author":"HW Findley","year":"1997","unstructured":"Findley, H.W., Gu, L., Yeager, A.M., and Zhou, M. (1997) Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood, 89, 2986\u20132993.","journal-title":"Blood"},{"key":"40_CR49","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/(SICI)1097-0215(19970611)71:6<959::AID-IJC9>3.0.CO;2-X","volume":"71","author":"GS Salomons","year":"1997","unstructured":"Salomons, G.S., Brady, H.J.M., Verwijs-Janssen, M., Van Den Berg, J.D., Hart, A.A.M., Van Den Berg, H., et al. (1997) The Bax\u03b1:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia. Int J Cancer, 71, 959\u2013965.","journal-title":"Int J Cancer"}],"container-title":["Advances in Experimental Medicine and Biology","Drug Resistance in Leukemia and Lymphoma III"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-4811-9_40","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T19:45:34Z","timestamp":1592941534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-4811-9_40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999]]},"ISBN":["9781461371809","9781461548119"],"references-count":49,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-4811-9_40","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999]]}}}